Boston Scientific inks $160m deal for peripheral stent maker Veniti

Boston Scientific inks $160m deal for peripheral stent maker Veniti

Source: 
Mass Device
snippet: 

Boston Scientific (NYSE:BSX) said today it inked a deal worth up to $160 million to acquire stent developer Veniti.